The Evidence Investigator analyser, based upon Randox’s award-winning Biochip Array Technology,
offers a flexible solution to those scientists interested in maximising the output from their
research through the benefits achievable from multiplex analysis.
It’s comprehensive test menu will appeal to researchers from a wide variety of disciplines
such as immunology, metabolic/nutritional research, oncology and cardiovascular disease making
it an ideal instrument for a core-lab facility. In addition, it now has the ability to
consolidate both proteomic and genomic applications onto a single platform with the advent
of our molecular diagnostics range of tests.
Introducing the MultiPlex Biochip Array Technology
In 1992, Randox created a concept that would transform laboratory testing; Biochip
Array Technology (BAT). The aim of this technology is to provide researchers
with as much diagnostic information as possible, faster and more efficiently than
The Food and Drug Association (FDA) cleared Biochip Array Technology which was subsequently
granted the prestigious MacRobert Award for Engineering. To date this technology has
transformed diagnostics worldwide, saving time and money within the laboratory and
allowing for highly accurate and informed clinical decisions.
Biochip Array Technology is a multi-analyte testing platform allowing the simultaneous
quantitative or qualitative detection of a wide range of analytes from a single sample.
It provides a unique platform for assessment of biological samples in a rapid, accurate
and easy to use format.